Loading viewer...
investor_presentation
Format: PDF investor_presentation
Leading independent biologics CDMO offering comprehensive services from cell line development through commercial manufacturing. Company highlights experienced management, recent facility expansions in mammalian and cell/gene therapy capabilities, and a strong regulatory track record serving a growing biopharmaceutical pipeline.
Yalla Group 2021 Analyst Day Keynote Presentation
investor_presentationinvestor_presentation
34 Pages
Yalla Group Limited
investor_presentation
Colfax